Lingonberry polyphenols: Potential SARS-CoV-2 inhibitors as nutraceutical tools?

Pirjo Pärnänen; Hanna Lähteenmäki; Ismo Räisänen; Taina Tervahartiala; Timo Sorsa

doi:10.14814/phy2.14741

Lingonberry polyphenols: Potential SARS-CoV-2 inhibitors as nutraceutical tools?

Physiol Rep. 2021 Feb;9(3):e14741. doi: 10.14814/phy2.14741.

Authors

Pirjo Pärnänen¹, Hanna Lähteenmäki¹, Ismo Räisänen¹, Taina Tervahartiala¹, Timo Sorsa^{1

2}

Affiliations

¹ Faculty of Medicine, Department of Oral and Maxillofacial Diseases, Head and Neck Center, University of Helsinki and Helsinki University Hospital, Finland.
² Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.

Abstract

Proposed pathway of the effect of lingonberry polyphenols on oral microbial (viral) load reduction and consequent beneficial local and systemic (respiratory tract) anti-inflammatory and antimicrobial/antiviral effects.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19*
Dietary Supplements
Humans
Oral Hygiene
Polyphenols / pharmacology
SARS-CoV-2
Vaccinium vitis-idaea*

Substances

Polyphenols

Abstract

Publication types

MeSH terms

Substances

Grants and funding